Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020831
Company: NOVARTIS
Company: NOVARTIS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
FORADIL | FORMOTEROL FUMARATE | 0.012MG/INH **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INHALATION | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/16/2001 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20831_Foradil_prntlbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20831_Foradil_approv.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20831_Foradil.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
03/02/2016 | SUPPL-34 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/13/2013 | SUPPL-33 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/29/2013 | SUPPL-32 | REMS-Modified |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020831s029,s032ltr.pdf |
04/17/2013 | SUPPL-31 | Manufacturing (CMC) |
Label is not available on this site. |
||
02/08/2013 | SUPPL-30 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/29/2013 | SUPPL-29 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020831s029,s032ltr.pdf |
09/27/2012 | SUPPL-28 | Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020831s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020831Orig1s028ltr.pdf | |
03/20/2012 | SUPPL-27 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020831s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020831s027ltr.pdf | |
05/03/2011 | SUPPL-25 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020831s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020831s025ltr.pdf | |
02/09/2011 | SUPPL-24 | Labeling-Package Insert |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020831s024ltr.pdf |
05/18/2011 | SUPPL-22 | REMS-Proposal |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020831s022ltr.pdf |
06/02/2010 | SUPPL-21 | Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020831s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020831s021,021592s003ltr.pdf | |
06/19/2006 | SUPPL-9 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020831s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020831s009LTR.pdf | |
06/27/2003 | SUPPL-5 | Efficacy-New Patient Population |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20831se5-005_foradil_lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20831se5-005ltr.pdf | |
05/17/2002 | SUPPL-4 | Manufacturing (CMC) |
Label is not available on this site. |
||
11/21/2001 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/25/2001 | SUPPL-2 | Labeling |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20831s2lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2001/21279ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/020831_S002_FORADIL_AP.pdf | |
04/25/2001 | SUPPL-1 | Manufacturing (CMC)-Control |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
09/27/2012 | SUPPL-28 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020831s028lbl.pdf | |
03/20/2012 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020831s027lbl.pdf | |
05/03/2011 | SUPPL-25 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020831s025lbl.pdf | |
06/02/2010 | SUPPL-21 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020831s021lbl.pdf | |
06/19/2006 | SUPPL-9 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020831s009lbl.pdf | |
06/27/2003 | SUPPL-5 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20831se5-005_foradil_lbl.pdf | |
09/25/2001 | SUPPL-2 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/20831s2lbl.pdf | |
02/16/2001 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20831_Foradil_prntlbl.pdf |